Page last updated: 2024-10-27

foscarnet and Nausea

foscarnet has been researched along with Nausea in 2 studies

Foscarnet: An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpesviruses and HIV.
phosphonoformic acid : Phosphoric acid in which one of the hydroxy groups is replaced by a carboxylic acid group. It is used as the trisodium salt as an antiviral agent in the treatment of cytomegalovirus retinitis (CMV retinitis, an inflamation of the retina that can lead to blindness) and as an alternative to ganciclovir for AIDS patients who require concurrent antiretroviral therapy but are unable to tolerate ganciclovir due to haematological toxicity.

Nausea: An unpleasant sensation in the stomach usually accompanied by the urge to vomit. Common causes are early pregnancy, sea and motion sickness, emotional stress, intense pain, food poisoning, and various enteroviruses.

Research Excerpts

ExcerptRelevanceReference
"Foscarnet is a safe and effective agent for prevention of CMV disease in allogeneic transplant recipients unable to receive ganciclovir."2.68Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir. ( Andersson, B; Champlin, R; Gajewski, J; Giralt, S; Ippoliti, C; Khouri, I; Mehra, R; Morgan, A; Przepiorka, D; van Besien, K; Warkentin, D, 1997)
"Penile ulcers are best managed by stopping the infusion until the ulcers heal; they may be prevented by paying careful attention to personal hygiene."2.40Minimising the dosage-limiting toxicities of foscarnet induction therapy. ( Jayaweera, DT, 1997)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jayaweera, DT1
Ippoliti, C1
Morgan, A1
Warkentin, D1
van Besien, K1
Mehra, R1
Khouri, I1
Giralt, S1
Gajewski, J1
Champlin, R1
Andersson, B1
Przepiorka, D1

Reviews

1 review available for foscarnet and Nausea

ArticleYear
Minimising the dosage-limiting toxicities of foscarnet induction therapy.
    Drug safety, 1997, Volume: 16, Issue:4

    Topics: Animals; Antiviral Agents; Cytomegalovirus Infections; Dose-Response Relationship, Drug; Female; Fos

1997

Trials

1 trial available for foscarnet and Nausea

ArticleYear
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir.
    Bone marrow transplantation, 1997, Volume: 20, Issue:6

    Topics: Actuarial Analysis; Adolescent; Adult; Bone Marrow Transplantation; Cytomegalovirus Infections; Fema

1997